Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

BAT to Invest CAD 187.5 Million in Organigram Through Private Placement

By Public Technologies
  • British American Tobacco will subscribe for 141,000,000 Organigram shares at CAD 1.33 each through a concurrent private placement.
  • The investment will raise GBP 100 million (CAD 187.5 million) to fund the Aurora acquisition’s cash consideration and transaction expenses.
  • The acquisition values Aurora at approximately CAD 561 million, with consideration of CAD 7.80 per share.
  • BAT will receive non-voting Class A convertible preferred shares instead of common shares where its common-share ownership would exceed 30%.
  • The placement will close concurrently with the acquisition, expected in January 2027, subject to shareholder, regulatory and court approvals.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OrganiGram Global Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261103746636) on November 03, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.